Temocapril: Difference between revisions
Appearance
Content deleted Content added
added ref |
|||
(3 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{more citations needed|date=January 2021}} |
{{more citations needed|date=January 2021}} |
||
Line 53: | Line 54: | ||
<!-- Definition and medical uses --> |
<!-- Definition and medical uses --> |
||
'''Temocapril''' (also known as ''temocaprilum'' [Latin]; brand name Acecol) is an [[ACE inhibitor]]. It was not approved for use in the [[United States|US]]. |
'''Temocapril''' (also known as ''temocaprilum'' [Latin]; brand name Acecol) is an [[ACE inhibitor]]. It was not approved for use in the [[United States|US]]. |
||
It is administered as inactive [[prodrug]], then converted to its active metabolite, temocaprilat.<ref>Yasunari, K., Maeda, K., Nakamura, M., Watanabe, T., Yoshikawa, J., & Asada, A. (2004). Pharmacological and clinical studies with temocapril, an angiotensin converting enzyme inhibitor that is excreted in the bile. Cardiovascular drug reviews, 22(3), 189–198. https://doi.org/10.1111/j.1527-3466.2004.tb00140.x</ref> |
|||
<!-- Society and culture --> |
<!-- Society and culture --> |
||
Line 75: | Line 78: | ||
{{cardiovascular-drug-stub}} |
{{cardiovascular-drug-stub}} |
||
{{stereochemistry-stub}} |
Latest revision as of 00:11, 28 January 2024
This article needs additional citations for verification. (January 2021) |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H28N2O5S2 |
Molar mass | 476.61 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Temocapril (also known as temocaprilum [Latin]; brand name Acecol) is an ACE inhibitor. It was not approved for use in the US.
It is administered as inactive prodrug, then converted to its active metabolite, temocaprilat.[1]
It was patented in 1984 and approved for medical use in 1994.[2]
References
[edit]- ^ Yasunari, K., Maeda, K., Nakamura, M., Watanabe, T., Yoshikawa, J., & Asada, A. (2004). Pharmacological and clinical studies with temocapril, an angiotensin converting enzyme inhibitor that is excreted in the bile. Cardiovascular drug reviews, 22(3), 189–198. https://doi.org/10.1111/j.1527-3466.2004.tb00140.x
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 469. ISBN 9783527607495.